Align Technology (ALGN) Competitors

$160.53 -1.22 (-0.75%)

Closing price 05/14/2026 04:00 PM Eastern

Extended Trading

$161.00 +0.47 (+0.29%)

As of 07:01 AM Eastern

ALGN vs. DXCM, HQY, HSIC, MEDP, and QTRX

Should you buy Align Technology stock or one of its competitors? MarketBeat compares Align Technology with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Align Technology include DexCom (DXCM), HealthEquity (HQY), Henry Schein (HSIC), Medpace (MEDP), and Quanterix (QTRX). These companies are all part of the "medical" sector.

How does Align Technology compare to DexCom?

Align Technology (NASDAQ:ALGN) and DexCom (NASDAQ:DXCM) are both large-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, valuation, analyst recommendations, risk, media sentiment, earnings, dividends and institutional ownership.

Align Technology presently has a consensus target price of $205.85, suggesting a potential upside of 28.23%. DexCom has a consensus target price of $83.22, suggesting a potential upside of 43.92%. Given DexCom's stronger consensus rating and higher probable upside, analysts plainly believe DexCom is more favorable than Align Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Align Technology	0 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.57
DexCom	1 Sell rating(s)	3 Hold rating(s)	18 Buy rating(s)	3 Strong Buy rating(s)	2.92

DexCom has higher revenue and earnings than Align Technology. DexCom is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Align Technology	$4.03B	2.85	$410.35M	$5.96	26.93
DexCom	$4.66B	4.79	$836.30M	$2.34	24.71

Align Technology has a beta of 1.7, suggesting that its share price is 70% more volatile than the broader market. Comparatively, DexCom has a beta of 1.4, suggesting that its share price is 40% more volatile than the broader market.

88.4% of Align Technology shares are held by institutional investors. Comparatively, 97.8% of DexCom shares are held by institutional investors. 0.8% of Align Technology shares are held by company insiders. Comparatively, 0.3% of DexCom shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

DexCom has a net margin of 19.31% compared to Align Technology's net margin of 10.50%. DexCom's return on equity of 33.33% beat Align Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Align Technology	10.50%	15.82%	10.17%
DexCom	19.31%	33.33%	13.19%

In the previous week, DexCom had 12 more articles in the media than Align Technology. MarketBeat recorded 19 mentions for DexCom and 7 mentions for Align Technology. DexCom's average media sentiment score of 0.90 beat Align Technology's score of 0.84 indicating that DexCom is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Align Technology	4 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
DexCom	9 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

DexCom beats Align Technology on 13 of the 17 factors compared between the two stocks.

How does Align Technology compare to HealthEquity?

HealthEquity (NASDAQ:HQY) and Align Technology (NASDAQ:ALGN) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, dividends, risk, profitability, institutional ownership and media sentiment.

HealthEquity currently has a consensus target price of $111.79, suggesting a potential upside of 35.79%. Align Technology has a consensus target price of $205.85, suggesting a potential upside of 28.23%. Given HealthEquity's stronger consensus rating and higher probable upside, research analysts plainly believe HealthEquity is more favorable than Align Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	1 Strong Buy rating(s)	2.87
Align Technology	0 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.57

HealthEquity has a beta of 0.19, suggesting that its stock price is 81% less volatile than the broader market. Comparatively, Align Technology has a beta of 1.7, suggesting that its stock price is 70% more volatile than the broader market.

In the previous week, Align Technology had 2 more articles in the media than HealthEquity. MarketBeat recorded 7 mentions for Align Technology and 5 mentions for HealthEquity. HealthEquity's average media sentiment score of 1.26 beat Align Technology's score of 0.84 indicating that HealthEquity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HealthEquity	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Align Technology	4 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

HealthEquity has a net margin of 16.39% compared to Align Technology's net margin of 10.50%. Align Technology's return on equity of 15.82% beat HealthEquity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthEquity	16.39%	13.86%	8.67%
Align Technology	10.50%	15.82%	10.17%

Align Technology has higher revenue and earnings than HealthEquity. Align Technology is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthEquity	$1.31B	5.29	$215.20M	$2.46	33.46
Align Technology	$4.03B	2.85	$410.35M	$5.96	26.93

99.6% of HealthEquity shares are owned by institutional investors. Comparatively, 88.4% of Align Technology shares are owned by institutional investors. 1.5% of HealthEquity shares are owned by company insiders. Comparatively, 0.8% of Align Technology shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

HealthEquity beats Align Technology on 10 of the 17 factors compared between the two stocks.

How does Align Technology compare to Henry Schein?

Henry Schein (NASDAQ:HSIC) and Align Technology (NASDAQ:ALGN) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, dividends, risk, profitability, institutional ownership and media sentiment.

Henry Schein currently has a consensus target price of $86.83, suggesting a potential upside of 19.59%. Align Technology has a consensus target price of $205.85, suggesting a potential upside of 28.23%. Given Align Technology's stronger consensus rating and higher probable upside, analysts plainly believe Align Technology is more favorable than Henry Schein.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Henry Schein	1 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.36
Align Technology	0 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.57

Henry Schein has a beta of 0.82, suggesting that its stock price is 18% less volatile than the broader market. Comparatively, Align Technology has a beta of 1.7, suggesting that its stock price is 70% more volatile than the broader market.

In the previous week, Henry Schein had 1 more articles in the media than Align Technology. MarketBeat recorded 8 mentions for Henry Schein and 7 mentions for Align Technology. Henry Schein's average media sentiment score of 1.58 beat Align Technology's score of 0.84 indicating that Henry Schein is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Henry Schein	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Align Technology	4 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Align Technology has a net margin of 10.50% compared to Henry Schein's net margin of 2.95%. Align Technology's return on equity of 15.82% beat Henry Schein's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Henry Schein	2.95%	15.44%	5.53%
Align Technology	10.50%	15.82%	10.17%

Align Technology has lower revenue, but higher earnings than Henry Schein. Henry Schein is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Henry Schein	$13.18B	0.63	$398M	$3.31	21.94
Align Technology	$4.03B	2.85	$410.35M	$5.96	26.93

96.6% of Henry Schein shares are owned by institutional investors. Comparatively, 88.4% of Align Technology shares are owned by institutional investors. 0.9% of Henry Schein shares are owned by company insiders. Comparatively, 0.8% of Align Technology shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Align Technology beats Henry Schein on 11 of the 16 factors compared between the two stocks.

How does Align Technology compare to Medpace?

Medpace (NASDAQ:MEDP) and Align Technology (NASDAQ:ALGN) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and media sentiment.

Medpace has higher earnings, but lower revenue than Align Technology. Medpace is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medpace	$2.53B	4.73	$451.12M	$15.91	26.35
Align Technology	$4.03B	2.85	$410.35M	$5.96	26.93

78.0% of Medpace shares are owned by institutional investors. Comparatively, 88.4% of Align Technology shares are owned by institutional investors. 20.5% of Medpace shares are owned by insiders. Comparatively, 0.8% of Align Technology shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Medpace currently has a consensus target price of $467.08, suggesting a potential upside of 11.43%. Align Technology has a consensus target price of $205.85, suggesting a potential upside of 28.23%. Given Align Technology's stronger consensus rating and higher possible upside, analysts plainly believe Align Technology is more favorable than Medpace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medpace	1 Sell rating(s)	10 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.20
Align Technology	0 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.57

Medpace has a beta of 1.19, suggesting that its share price is 19% more volatile than the broader market. Comparatively, Align Technology has a beta of 1.7, suggesting that its share price is 70% more volatile than the broader market.

In the previous week, Medpace had 26 more articles in the media than Align Technology. MarketBeat recorded 33 mentions for Medpace and 7 mentions for Align Technology. Align Technology's average media sentiment score of 0.84 beat Medpace's score of 0.27 indicating that Align Technology is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medpace	5 Very Positive mention(s)	0 Positive mention(s)	26 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
Align Technology	4 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Medpace has a net margin of 17.19% compared to Align Technology's net margin of 10.50%. Medpace's return on equity of 120.89% beat Align Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medpace	17.19%	120.89%	24.79%
Align Technology	10.50%	15.82%	10.17%

Summary

Medpace and Align Technology tied by winning 8 of the 16 factors compared between the two stocks.

How does Align Technology compare to Quanterix?

Quanterix (NASDAQ:QTRX) and Align Technology (NASDAQ:ALGN) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and media sentiment.

Align Technology has higher revenue and earnings than Quanterix. Quanterix is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quanterix	$138.90M	0.94	-$107.15M	-$2.36	N/A
Align Technology	$4.03B	2.85	$410.35M	$5.96	26.93

86.5% of Quanterix shares are owned by institutional investors. Comparatively, 88.4% of Align Technology shares are owned by institutional investors. 1.5% of Quanterix shares are owned by insiders. Comparatively, 0.8% of Align Technology shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Quanterix currently has a consensus target price of $4.00, suggesting a potential upside of 44.40%. Align Technology has a consensus target price of $205.85, suggesting a potential upside of 28.23%. Given Quanterix's higher possible upside, equities analysts plainly believe Quanterix is more favorable than Align Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quanterix	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
Align Technology	0 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.57

Quanterix has a beta of 1.15, suggesting that its share price is 15% more volatile than the broader market. Comparatively, Align Technology has a beta of 1.7, suggesting that its share price is 70% more volatile than the broader market.

In the previous week, Quanterix had 4 more articles in the media than Align Technology. MarketBeat recorded 11 mentions for Quanterix and 7 mentions for Align Technology. Align Technology's average media sentiment score of 0.84 beat Quanterix's score of 0.03 indicating that Align Technology is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Quanterix	0 Very Positive mention(s)	0 Positive mention(s)	8 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Align Technology	4 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Align Technology has a net margin of 10.50% compared to Quanterix's net margin of -71.86%. Align Technology's return on equity of 15.82% beat Quanterix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Quanterix	-71.86%	-23.92%	-17.66%
Align Technology	10.50%	15.82%	10.17%

Summary

Align Technology beats Quanterix on 13 of the 16 factors compared between the two stocks.

Get Align Technology News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ALGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ALGN vs. The Competition

Export

Metric	Align Technology	MED/DENTAL Industry	Medical Sector	NASDAQ Exchange
Market Cap	$11.58B	$14.72B	$6.34B	$12.37B
Dividend Yield	N/A	2.12%	2.80%	5.35%
P/E Ratio	26.93	17.49	20.66	25.63
Price / Sales	2.85	2.16	547.76	76.59
Price / Cash	13.63	12.71	43.26	56.33
Price / Book	2.77	2.99	9.88	6.97
Net Income	$410.35M	$534.24M	$3.55B	$333.62M
7 Day Performance	-4.89%	3.78%	1.69%	1.09%
1 Month Performance	-13.94%	1.75%	0.48%	3.08%
1 Year Performance	-14.03%	-6.23%	39.39%	35.68%

Align Technology Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ALGN Align Technology	4.1708 of 5 stars	$160.53 -0.8%	$205.85 +28.2%	-14.5%	$11.58B	$4.03B	26.93	20,290
DXCM DexCom	4.8218 of 5 stars	$59.33 -2.1%	$83.50 +40.7%	-33.2%	$23.39B	$4.66B	25.35	11,000	Positive News
HQY HealthEquity	4.1959 of 5 stars	$81.65 -3.8%	$111.79 +36.9%	-16.1%	$7.17B	$1.31B	33.19	2,814	Positive News
HSIC Henry Schein	3.7892 of 5 stars	$68.99 -2.6%	$86.83 +25.9%	+3.6%	$8.07B	$13.18B	20.84	25,000	Insider Trade
MEDP Medpace	3.2415 of 5 stars	$417.29 -1.6%	$467.08 +11.9%	+43.7%	$12.11B	$2.53B	26.23	6,200	Trending News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ALGN) was last updated on 5/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Align Technology (ALGN) Competitors

ALGN vs. DXCM, HQY, HSIC, MEDP, and QTRX

How does Align Technology compare to DexCom?

Summary

How does Align Technology compare to HealthEquity?

Summary

How does Align Technology compare to Henry Schein?

Summary

How does Align Technology compare to Medpace?

Summary

How does Align Technology compare to Quanterix?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ALGN vs. The Competition

Align Technology Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Align Technology (ALGN) Competitors

ALGN vs. DXCM, HQY, HSIC, MEDP, and QTRX

How does Align Technology compare to DexCom?

Do analysts prefer ALGN or DXCM?

Which has higher earnings and valuation, ALGN or DXCM?

Which has more risk & volatility, ALGN or DXCM?

Do institutionals & insiders have more ownership in ALGN or DXCM?

Is ALGN or DXCM more profitable?

Does the media prefer ALGN or DXCM?

Summary

How does Align Technology compare to HealthEquity?

Do analysts recommend HQY or ALGN?

Which has more volatility & risk, HQY or ALGN?

Does the media favor HQY or ALGN?

Is HQY or ALGN more profitable?

Which has better valuation and earnings, HQY or ALGN?

Do insiders and institutionals hold more shares of HQY or ALGN?

Summary

How does Align Technology compare to Henry Schein?

Do analysts recommend HSIC or ALGN?

Which has more volatility & risk, HSIC or ALGN?

Does the media favor HSIC or ALGN?

Is HSIC or ALGN more profitable?

Which has better valuation and earnings, HSIC or ALGN?

Do insiders and institutionals hold more shares of HSIC or ALGN?

Summary

How does Align Technology compare to Medpace?

Which has preferable valuation & earnings, MEDP or ALGN?

Do institutionals and insiders hold more shares of MEDP or ALGN?

Do analysts prefer MEDP or ALGN?

Which has more risk & volatility, MEDP or ALGN?

Does the media refer more to MEDP or ALGN?

Is MEDP or ALGN more profitable?

Summary

How does Align Technology compare to Quanterix?

Which has preferable valuation & earnings, QTRX or ALGN?

Do institutionals and insiders hold more shares of QTRX or ALGN?

Do analysts prefer QTRX or ALGN?

Which has more risk & volatility, QTRX or ALGN?

Does the media refer more to QTRX or ALGN?

Is QTRX or ALGN more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ALGN vs. The Competition

Align Technology Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools